Austin, May 28, 2025 (GLOBE NEWSWIRE) — According to SNS Insider, The Cell Therapy Human Raw Materials Market\u00a0<\/a><\/b>was valued at\u00a0USD 2.9 billion\u00a0in 2023 and is projected to reach\u00a0USD 18.1 billion by 2032, growing at an impressive\u00a0CAGR of 22.6% from 2024 to 2032. This remarkable growth is driven by the increasing demand for cell-based therapies across various medical applications and the need for high-quality raw materials to support cell culture, growth, and therapeutic efficacy.<\/p>\n Get a Sample Report of Cell Therapy Human Raw Materials Market@\u00a0https:\/\/www.snsinsider.com\/sample-request\/4487<\/a><\/b><\/p>\n Market Overview<\/b><\/p>\n The\u00a0Cell Therapy Human Raw Materials Market\u00a0is experiencing significant growth due to the increasing demand for\u00a0cell-based therapies\u00a0such as\u00a0stem cell therapy,\u00a0regenerative medicine, and\u00a0CAR-T cell therapy. With advancements in biotechnology, the need for\u00a0high-quality raw materials, including\u00a0cell culture media,\u00a0growth factors, and\u00a0cryopreservation reagents, has surged. The supply chain for these materials is expanding, with leading biotechnology companies and research institutions investing heavily in R&D and production capabilities.<\/p>\n The rising focus on\u00a0personalized medicine\u00a0and\u00a0gene editing technologies\u00a0is further propelling the demand for specialized raw materials. Companies are working to ensure a stable supply of critical components, while regulatory bodies emphasize the safety and efficacy of these materials. The growing number of clinical trials and commercialization efforts in\u00a0cell therapy applications\u00a0is driving both demand and supply in the market.<\/p>\n Major Players Analysis Listed in this Report are:<\/b><\/p>\n Cell Therapy Human Raw Materials Market Report Scope<\/b><\/p>\n Segment Analysis<\/b><\/p>\n By Product:<\/b><\/p>\n The\u00a0Cell Culture Media\u00a0segment dominated the market in 2023, accounting for about\u00a040% of the market share. This segment is crucial for\u00a0cell therapy applications\u00a0as it provides the necessary environment for\u00a0cell growth,\u00a0differentiation, and functionality. The increasing demand for\u00a0advanced and specialized media, particularly for therapies like\u00a0stem cell\u00a0and\u00a0CAR-T cell therapy, drives the growth of this segment. Companies are focusing on developing media formulations tailored to specific cell types, ensuring optimal therapeutic outcomes.<\/p>\n By End-Use:<\/b><\/p>\n The\u00a0Biotechnology & Pharmaceutical Companies\u00a0segment held the largest market share, estimated at\u00a055%\u00a0in 2023. These companies are heavily investing in the development and commercialization of\u00a0cell-based therapies, driving the demand for high-quality raw materials. With significant investments in\u00a0gene editing,\u00a0regenerative medicine, and other cutting-edge therapies, the need for reliable and specialized raw materials is critical for research, clinical trials, and large-scale production.<\/p>\n Cell Therapy Human Raw Materials Market Segmentation<\/b><\/p>\n By Product<\/b><\/p>\n By End-Use<\/b><\/p>\n Regional Analysis<\/b><\/p>\n North America\u00a0dominated the\u00a0Cell Therapy Human Raw Materials Market\u00a0in 2023, accounting for a significant market share. The region’s growth is attributed to the presence of major\u00a0biotechnology companies, advanced research facilities, and substantial government funding for\u00a0cell therapy research. The U.S., in particular, is at the forefront of innovations in\u00a0regenerative medicine\u00a0and\u00a0gene therapies, with companies like\u00a0Novartis\u00a0and\u00a0Gilead Sciences\u00a0leading the market. The high adoption of\u00a0cell-based therapies, combined with strong regulatory support, positions\u00a0North America\u00a0as the dominant region.<\/p>\n Asia Pacific\u00a0is expected to be the\u00a0fastest-growing region\u00a0during the forecast period. Countries such as\u00a0China,\u00a0Japan, and\u00a0South Korea\u00a0are making substantial investments in\u00a0biotechnology\u00a0and\u00a0cell therapy research. The region is witnessing a surge in clinical trials and government initiatives supporting\u00a0regenerative medicine. Companies like\u00a0Takeda Pharmaceuticals\u00a0and\u00a0Samsung Biologics\u00a0are expanding their production capabilities, contributing to the rapid growth of the market in\u00a0Asia Pacific.<\/p>\n Buy a Single-User PDF of Cell Therapy Human Raw Materials Market Analysis & Outlook Report 2024-2032@ https:\/\/www.snsinsider.com\/checkout\/4487<\/a><\/b><\/p>\n Recent Developments<\/b><\/p>\n Key Takeaways<\/b><\/p>\n Table of Contents \u2013 Major Key Points<\/b><\/p>\n 1. Introduction<\/p>\n 2. Executive Summary<\/p>\n 3. Research Methodology<\/p>\n 4. Market Dynamics Impact Analysis<\/p>\n 5. Statistical Insights and Trends Reporting<\/p>\n 6. Competitive Landscape<\/p>\n 7. Cell Therapy Human Raw Materials Market by Product<\/p>\n 8. Cell Therapy Human Raw Materials Market by End-Use<\/p>\n 9. Regional Analysis<\/p>\n 10. Company Profiles<\/p>\n 11. Use Cases and Best Practices<\/p>\n 12. Conclusion<\/p>\n Related Reports<\/b><\/p>\n Global Cell Therapy Market to Soar to $28.98 Billion by 2032, Driven by 22.55% CAGR Through 2024\u20132032.<\/a><\/p>\n![](\"https:\/\/ml.globenewswire.com\/Resource\/Download\/5428166d-a458-4edd-9436-b41d95492f9d\/cell-therapy-human-raw-materials-market.jpg\" "\\"Cell-Therapy-Human-Raw-Materials-Market.jpg\\"")
<\/b><\/p>\n\n
\n
\n Report Attributes<\/b><\/td>\n Details<\/b><\/td>\n<\/tr>\n \n Market Size in 2023<\/td>\n US$ 2.9 billion<\/td>\n<\/tr>\n \n Market Size by 2032<\/td>\n US$ 18.1 billion<\/td>\n<\/tr>\n \n CAGR<\/td>\n CAGR of 22.6% From 2024 to 2032<\/td>\n<\/tr>\n \n Base Year<\/td>\n 2023<\/td>\n<\/tr>\n \n Forecast Period<\/td>\n 2024-2032<\/td>\n<\/tr>\n \n Historical Data<\/td>\n 2020-2022<\/td>\n<\/tr>\n \n Key Regional Coverage<\/td>\n North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)<\/td>\n<\/tr>\n \n Key Growth Drivers<\/td>\n Growing demand for cell-based treatments for chronic diseases and cancers is increasing the need for high-quality raw materials.<\/td>\n<\/tr>\n<\/table>\n \n
\n
\n
\n
\n
![\"\"](\"https:\/\/ml.globenewswire.com\/media\/NDNhNGExZTYtYjRhMC00YzViLWJjMDMtMDZjYmEwZTBmMmMwLTEyNjg4MTktMjAyNS0wNS0yOC1lbg==\/tiny\/SNS-Insider-pvt-ltd.png\")
\n <\/div>\n","protected":false},"excerpt":{"rendered":"